tirzepatide and metformin + for Weight Loss & Diabetes Is the combination of Mounjaro

Heres what neuroscience and clinical research actually show.

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for weight loss, and supplements for heart health.

An independent editorial review of Mochi

However, further research is needed to fully understand how these therapies exert their effect on body weight and in the last section we cover open questions about the potential mechanisms of multiagonist drugs, and the understanding of how gutbrain communication can be leveraged to achieve sustained body weight loss without adverse effects.

The Novo Nordisk-funded FLOW trial, published in the New England Journal of Medicine on 24 May 2024, randomly assigned patients with T2DM and []